AIT is indicated when the correlation between allergen-specific IgE and symptoms is documented (skin-prick tests, serological measurement of IgE), when pharmacotherapy is not sufficient to control clinical manifestations and for preventing the potential onset of new sensitizations or the worsening of the respiratory disease. Here, IGHE is linked to respiratory system disorder.